Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
暂无分享,去创建一个
Karin Haustermans | Marisol De Brabandere | Frank-André Siebert | Frank Van den Heuvel | Peter Hoskin | M. de Brabandere | K. Haustermans | P. Hoskin | F. Siebert | F. Van den Heuvel
[1] Ivan Yeung,et al. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy. , 2004, Brachytherapy.
[2] E Bellon,et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. , 1999, International journal of radiation oncology, biology, physics.
[3] J J Prete,et al. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. , 1998, Radiology.
[4] C. Giberti,et al. Dosimetry doesn't seem to predict the control of organ-confined prostate cancer after I-125 brachytherapy. Evaluation in 150 patients. , 2009, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.
[5] P. Mangili,et al. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] P. Grimm,et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. , 1999, International journal of radiation oncology, biology, physics.
[7] Dan Ash,et al. Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] L. Potters,et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. , 2001, International journal of radiation oncology, biology, physics.
[9] K. Wallner,et al. Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation. , 2007, International journal of radiation oncology, biology, physics.
[10] D. Ash,et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] Wendy L. Smith,et al. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. , 2007, International journal of radiation oncology, biology, physics.
[12] Patrick W McLaughlin,et al. The use of mutual information in registration of CT and MRI datasets post permanent implant. , 2004, Brachytherapy.
[13] D. Ash,et al. Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] D. Engeler,et al. Topological methods for the comparison of structures using LDR-brachytherapy of the prostate as an example , 2009, Physics in medicine and biology.
[15] Dan Ash,et al. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] W. Lee. Permanent prostate brachytherapy: the significance of postimplant dosimetry. , 2004, Reviews in urology.
[17] Christian Kirisits,et al. Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] J. Williamson,et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2004 .
[19] A. Agranovich,et al. Computed tomography determination of prostate volume and maximum dimensions: a study of interobserver variability. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] Phantom investigations on CT seed imaging for interstitial brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] R. Stock,et al. A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.
[22] J J Prete,et al. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. , 1998, Radiation oncology investigations.
[23] Roberto Orecchia,et al. MR and CT image fusion for postimplant analysis in permanent prostate seed implants. , 2004, International journal of radiation oncology, biology, physics.
[24] Alex Rijnders,et al. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] M van Herk,et al. Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.
[26] Wayne M Butler,et al. Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parameters. , 2011, Brachytherapy.
[27] M. Middleton,et al. Prostate contouring variation: can it be fixed? , 2012, International journal of radiation oncology, biology, physics.